Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Agrify

Flora Growth Corp

Intercure Ltd

PepsiCo

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we kick off 2022.

5 Cannabis Stocks to Watch Alongside MORE Act Momentum

Tilray stock received a boost recently as the US marijuana legalization cadence moved forward in the House of Representatives.

Is Tilray Stock A Buy, Sell, Or Hold After Earnings?

Aurora Cannabis

Canopy Growth

Legalizing pot in the U.S. could still be more difficult than some think.

Why Tilray, Canopy Growth, and Aurora Cannabis Stocks Dropped Early Monday

High Tide

Village Farms International

Are You Taking Advantage Of The Current Market? The post Are Top Canadian Stocks A Buy Right Now? How Active Traders Are Day Trading The Volatility appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Top Canadian Stocks A Buy Right Now? How Active Traders Are Day Trading The Volatility

A strong earnings report wasn't enough to overcome more macro issues.

Why Tilray Shares Have Been Sinking This Week

BioXcel Therapeutics

Merck

Could health care stocks be the play amidst the current volatility in markets?

Best Stocks To Buy Now? 3 Health Care Stocks For Your List

Trulieve Cannabis Corp.

Trulieve reported excellent revenues and profitability for FQ4'21, while Tilray posted impressive net income for FQ3'22.

Trulieve Vs. Tilray: Legalization May Not Be A Game Changer After All

Cronos Group

Cannabis Stocks: Near-Term Headwinds Don't Matter Much (Podcast Transcript)

The stock is down more than 7% this year but up more than 20% this month.

Why Tilray Shares Dropped 10.1% on Thursday

TLRY stock posted strong third quarter results, feeding into its long-term bullish case. The post Tilray's Earnings Are in, Here's What You Should Know appeared first on InvestorPlace.

Tilray's Earnings Are in, Here's What You Should Know

Tilray Reports Positive Earnings: Look Beyond The Headline Numbers

We Need To Talk About Cannabis (Podcast Transcript)

Tilray made money -- and progress toward its $4 billion annual revenue goal.

Does Tilray's Report Today Make the Stock a Buy?

Tilray Brands, Inc. (TLRY) CEO Irwin Simon on Q3 2022 Results - Earnings Call Transcript

OrganiGram Holdings Inc.

Are Canadian Pot Stocks A Buy For April? The post Best Canadian Marijuana Stocks To Buy In April? 3 Top Pot Stocks For Active Traders On The Nasdaq appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy In April? 3 Top Pot Stocks For Active Traders On The Nasdaq

Tilray stock is soaring after reporting an unexpected profit for its latest quarter and inking a deal with supermarket chain Whole Foods. The post Tilray Stock Is a Buy as It Blazes Higher on Today's Earnings appeared first on InvestorPlace.

Tilray Stock Is a Buy as It Blazes Higher on Today's Earnings

Investors are wondering if Tilray (TLRY) stock is a buy after the release of the marijuana company's earnings report for fiscal Q3 2022. The post Is TLRY Stock a Buy After Earnings?

Is TLRY Stock a Buy After Earnings? 3 Analysts Weigh In.

The pair of stocks thrived despite a falling market.

Tilray Is Smoking Higher, but This Energy Stock Was an Even Bigger Winner Wednesday

Canadian cannabis maker Tilray is up today after reporting its fiscal Q3 financial results. Let's look at what's going on with TLRY stock.

Why Is Tilray (TLRY) Stock Up 10% Today?

Tilray Inc. shares bucked a down market on Wednesday after the Canadian cannabis company posted a surprise profit and said it inked a distribution deal with Whole Foods for its Manitoba Harvest hemp products.

Tilray stock rallies as investors cheer Whole Foods deal and look past revenue miss

Shares of TLRY stock are climbing after the company reported positive non-GAAP earnings and a new partnership with Whole Foods. The post Why Tilray Stock Is Soaring Today appeared first on InvestorPlace.

Why Tilray Stock Is Soaring Today

Tilray announced a surprise profit and a new partnership with Whole Foods Market.

Why Tilray Shot Higher Today

U.S.-listed shares of cannabis stock Tilray Inc (NASDAQ:TLRY) are surging today, up 14.1% to trade at $8.02, after the company's fiscal third-quarter results.

Cannabis Stock Heats Up After Surprise Earnings Beat

Shares of Tilray Inc (NASDAQ: TLRY) are up more than 15% this morning after the cannabis company reported a surprise profit for its fiscal third quarter. What Tilray Q3 results tell us Net income came in at $43.19 million that translates to 9 cents a share.

Tilray Q3 results: we will deliver tangible shareholder value

Tilray Brands, Inc. (TLRY) delivered earnings and revenue surprises of 150% and 4.31%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Tilray Brands Stock (TLRY)